| Mon, Nov 9, 2009 | | | KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online (Mon 5:01pm)
| | | Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2009 Financial Results PR Newswire (Mon 4:30pm)
| | | AEterna Zentaris: Scientific Article Supports Perifosine's Development in Kidney Cancer PR Newswire (Mon 7:00am)
| | Fri, Nov 6, 2009 | | | Keryx Biopharmaceuticals, Inc. Earnings Call scheduled for Tue, Nov 10 CCBN (Fri, Nov 6)
| | | Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2009 Financial Results on Tuesday, November 10, 2009 at 8:30 a.m. EST PR Newswire (Fri, Nov 6)
| | Wed, Nov 4, 2009 | | | Keryx Biopharmaceuticals to Present at the Merriman Curhan Ford 6th Annual Investor Summit PR Newswire (Wed, Nov 4)
| | Fri, Oct 30, 2009 | | | One Bet You're Sure to Lose at Motley Fool (Fri, Oct 30)
| | Thu, Oct 29, 2009 | | | Keryx Biopharmaceuticals to Present at the Oppenheimer 20th Annual Healthcare Conference PR Newswire (Thu, Oct 29)
| | Tue, Oct 27, 2009 | | | Keryx Biopharmaceuticals' Next Price Movers Will Be Trial News at Seeking Alpha (Tue, Oct 27)
| | Mon, Oct 26, 2009 | | | Tomorrow's Monster Stock? at Motley Fool (Mon, Oct 26)
| | | Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentation of Zerenex (ferric citrate) for the Treatment of Hyperphosphatemia at the Upcoming American Society of Nephrology Renal Week Meeting in San Diego PR Newswire (Mon, Oct 26)
| | Fri, Oct 23, 2009 | | | 5 Cold Stocks Heating Up at Motley Fool (Fri, Oct 23)
| | Tue, Oct 20, 2009 | | | AKT Inhibitor Moving Into Phase III Trials: Ladenburg Thalmann Sees This As Catalyst For Investors Wall Street Transcript (Tue, Oct 20)
| | Thu, Oct 15, 2009 | | | Beacon Equity Issues Trading Overview for Keryx Biopharmaceuticals GlobeNewswire (Thu, Oct 15)
| | Wed, Oct 14, 2009 | | | 6 Stocks Attracting Top Investors at Motley Fool (Wed, Oct 14)
| | Tue, Oct 13, 2009 | | | 9 Stocks Shaking the Market at Motley Fool (Tue, Oct 13)
| | | These Stocks Can Easily Double Your Money at Motley Fool (Tue, Oct 13)
| | Fri, Oct 9, 2009 | | | Keryx Biopharma Investors Should Wait for More News on Trials at Seeking Alpha (Fri, Oct 9)
| | Thu, Oct 8, 2009 | | | 5 Stocks Bouncing Back at Motley Fool (Thu, Oct 8)
| | | Phase 2 Study of KRX-0401 (Perifosine) in Relapsed or Refractory Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma Open for Enrollment at Duke Comprehensive Cancer Center PR Newswire (Thu, Oct 8)
| Add KERX News to My Yahoo!:

| |
|